Mesenchymal stem cell- (MSC-) derived conditioned medium ameliorates lipopolysaccharide- (LPS-) induced lung injury, by attenuating lung inflammation and promoting a wound healing/anti-inflammatory M2 macrophage phenotype, possibly via paracrine mechanisms involving IGF-1 [169]. Here, IGF1 is linked to inflammatory response.